← Back to headlines




Eli Lilly's New Oral Weight-Loss Pill Foundayo Approved by FDA
Eli Lilly's new GLP-1 weight-loss pill, Foundayo, which is the first oral GLP-1 not requiring fasting, has been approved by the Food and Drug Administration and has shown effectiveness in clinical trials, with one user losing 25 pounds.
4 Apr, 10:09 — 4 Apr, 10:09
Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now

Four Arrested for Selling P102 Million in Counterfeit Anti-Cancer Medicine in Makati
just now
Oil Traffic Through Danish Straits Reaches Historic Highs, Raising Safety and Pollution Concerns
13m ago
Poland Increases Subsidies for Employees with Disabilities in 2026
26m ago